BML Investment Partners, L.P. - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for AN2 Therapeutics, Inc. (ANTX)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol: ANTX
Shares outstanding: 29.9M shares
Disclosed Ownership: 5.75M shares
Ownership: 19.2%
Form type: SCHEDULE 13G/A
Date filed: 2/13/2025, 04:28 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	19.2%	5.75M	0	5.75M	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member